Company Filing History:
2 out of 99 
1 out of 5 
1 out of 94 
Years Active: 2015-2022
Title: Innovations of Raphael Frederick in Proliferative Disorder Treatments
Introduction
Raphael Frederick is an accomplished inventor based in Godinne, Belgium. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications.
Latest Patents
Frederick holds a patent for "Beta carboline derivatives useful in the treatment of proliferative disorders." This invention provides novel beta-carboline derivatives of formulae (Ia) and (Ib) that are useful in treating proliferative disorders, including cancer. The patent also details the intermediates used in their preparation, the processes for preparing these compounds, and their various uses.
Career Highlights
Throughout his career, Raphael Frederick has worked with esteemed institutions such as Facultés Universitaires Notre-Dame de la Paix and Université Libre Bruxelles. His work has focused on advancing the understanding and treatment of serious health conditions.
Collaborations
Frederick has collaborated with notable colleagues, including Bernard Masereel and Jeremy Reniers, contributing to the advancement of research in his field.
Conclusion
Raphael Frederick's innovative work in developing beta-carboline derivatives showcases his commitment to improving treatment options for proliferative disorders. His contributions to medicinal chemistry are noteworthy and continue to impact the field positively.